Antimicrobial Susceptibilities of Clinical Desulfovibrio Isolates
The antimicrobial susceptibilities of 16 clinical isolates of Desulfovibrio spp. were determined. All or most isolates were susceptible to imipenem (MIC(90) [MIC at which 90% of the isolates tested were inhibited], 0.5 μg/ml), metronidazole (MIC(90), 0.25 μg/ml), clindamycin (MIC(90), 4 μg/ml), and...
Uloženo v:
| Vydáno v: | Antimicrob Agents Chemother |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society for Microbiology (ASM)
2001
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90757/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11557495/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.10.2933-2935.2001 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
